Mereo BioPharma Group plc
MREO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719714
No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Mereo BioPharma Group plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Mereo BioPharma Group plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wyzga Michael S | Director | 25,050 | Feb 27, 2026 | 1 |
| Pakianathan Deepika | Director | 0 | Feb 27, 2026 | 1 |
| Yoskowitz Marc J | Director | – | Feb 27, 2026 | 1 |
| Jenkins Annalisa | Director | – | Feb 27, 2026 | 1 |
| Jacquet Pierre | Director | – | Feb 27, 2026 | 1 |
| Bender Jeremy | Director | 12,550Indirect | Feb 27, 2026 | 1 |
| Shames Daniel | Director | – | Feb 27, 2026 | 1 |
| Ekblom Anders | Director | – | Feb 27, 2026 | 1 |
| Scots-Knight Denise | Chief Executive Officer | 808,921 | Feb 2, 2026 | 1 |
| Lewicki John A. | Chief Scientific Officer | 78,630 | Feb 2, 2026 | 1 |
| Sermon Charles | General Counsel | 219,061 | Feb 2, 2026 | 1 |
| Fox Christine Ann | Chief Financial Officer | 89,285 | Feb 2, 2026 | 1 |
| Hughes-Wilson Alexandra | See Remarks | 50,475 | Feb 2, 2026 | 1 |
| Rubric Capital Management LP | 10% Owner | – | Jun 17, 2024 | 0 |
| Rosen David Efraim | 10% Owner | – | Jun 17, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Scots-Knight DeniseChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −88.7K | $4.30 | −$381.3K | −9.9%808.9K after | 2 lots |
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Lewicki John A.Chief Scientific Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −16.1K | $4.30 | −$69.5K | −17.0%78.6K after | 2 lots |
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Sermon CharlesGeneral Counsel | SSaleAmerican Depositary Shares representing Ordinary Shares | −30.9K | $4.30 | −$133.0K | −12.4%219.1K after | 2 lots |
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Fox Christine AnnChief Financial Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −28.3K | $4.30 | −$121.6K | −24.1%89.3K after | 2 lots |
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Hughes-Wilson AlexandraSee Remarks | SSaleAmerican Depositary Shares representing Ordinary Shares | −148.1K | $4.30 | −$637.0K | −74.6%50.5K after | 4 lots |
| Aug 23, 2024 (view filing) | Aug 22 | 1 day | Pakianathan DeepikaDirector | SSaleAmerican Depositary Shares representing Ordinary Shares | −105.2K | $4.43 | −$466.2K | −100.0%0 after | |
| Jun 27, 2024 (view filing) | Jun 25-26 | 2 days | Sermon CharlesGeneral Counsel | SSaleAmerican Depositary Shares representing Ordinary Shares | −46.4K | $3.48 | −$161.5K | −20.1%184.4K after | 2 lots |
| Jun 27, 2024 (view filing) | Jun 25-26 | 2 days | Lewicki John A.Chief Scientific Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −24.2K | $3.48 | −$84.3K | −33.2%48.8K after | 2 lots |
| Jun 27, 2024 (view filing) | Jun 25-26 | 2 days | Fox Christine AnnChief Financial Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −42.4K | $3.48 | −$147.7K | −42.4%57.6K after | 2 lots |
| Jun 27, 2024 (view filing) | Jun 25-26 | 2 days | Scots-Knight DeniseChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −133.0K | $3.48 | −$463.0K | −15.8%709.5K after | 2 lots |
| Jun 27, 2024 (view filing) | Jun 25-26 | 2 days | Hughes-Wilson AlexandraSee Remarks | SSaleAmerican Depositary Shares representing Ordinary Shares | −33.1K | $3.48 | −$115.3K | −48.9%34.5K after | 2 lots |